Medullary Sponge Kidney
Medullary sponge kidney (MSK) is a congenital condition characterized by abnormal dilation of the small tubules that carry urine within the medullary (inner) portion of the kidney. The dilated tubules give the medullary tissue a spongelike appearance on certain imaging studies and predispose to the formation of small calcifications (calcium deposits) and kidney stones. Many people with MSK have no symptoms and are identified incidentally on imaging done for other reasons. Others experience recurrent kidney stones, urinary tract infections, or blood in the urine. Kidney function is usually preserved throughout life, and MSK does not typically progress to kidney failure. Evaluation combines imaging (particularly CT urography), stone workup, and management of any complications.
What is it?
The kidney’s tissue is broadly divided into two portions: the outer cortex, which contains most of the filtering units, and the inner medulla, which contains the collecting tubules that concentrate urine before it drains into the collecting system. The medulla is organized into pyramid-shaped structures called renal pyramids, with the tips of the pyramids (renal papillae) draining urine into the small cups of the collecting system (calyces).
Medullary sponge kidney (MSK) is a congenital condition in which the small tubules (called collecting ducts, particularly those near the renal papillae) become abnormally dilated—forming small cystic spaces within the medullary tissue. On certain imaging studies, this dilation gives the medulla a spongelike appearance, which is where the condition gets its name. The dilated tubules provide areas of urinary stasis, which predisposes to the formation of small calcifications and, in some patients, larger kidney stones. Small calcifications within the medulla are called medullary nephrocalcinosis and are a characteristic imaging finding of MSK, though they can also be seen in other conditions.
The exact cause of MSK is not well understood. It is generally thought to develop during fetal kidney development, and most cases occur sporadically without a clear inherited pattern. However, MSK has been described in association with certain congenital conditions and syndromes, including Beckwith-Wiedemann syndrome, congenital hemihypertrophy, Ehlers-Danlos syndrome, and others. Some familial cases have been reported. Both kidneys are typically affected, though the extent may vary between kidneys and between different parts of the same kidney.
The clinical significance of MSK varies widely. Many people with MSK have no symptoms and normal kidney function throughout life, and the condition is identified incidentally on imaging done for other reasons. Others experience recurrent kidney stones, urinary tract infections, blood in the urine, or chronic mild flank discomfort. Kidney stones in patients with MSK are often smaller and multiple, and patients may pass many stones over time. Progression to significantly reduced kidney function or kidney failure is uncommon, and MSK is considered a generally benign condition in terms of long-term kidney health.
Several metabolic abnormalities are commonly associated with MSK and contribute to stone formation. These may include high urine calcium (hypercalciuria), which is present in a notable proportion of patients with MSK; distal renal tubular acidosis (a condition of impaired ability to acidify the urine, which contributes to certain types of stone formation and, when present, may require specific treatment); low urine citrate (hypocitraturia); and other findings. Identifying and treating these metabolic contributors is an important part of stone prevention in MSK.
Kidney stones in MSK are most often made of calcium phosphate or a mixture of calcium phosphate and calcium oxalate, though the specific composition varies. Small calcifications that remain within the dilated tubules typically cause no symptoms, but stones that break free and enter the collecting system can cause the classic symptoms of stones, including renal colic (severe waves of flank or back pain), blood in the urine, nausea, vomiting, and, when combined with infection, urinary tract infection symptoms and, in serious cases, sepsis.
Symptoms of MSK, when they occur, are typically related to stones or infection rather than to the anatomical variation itself. Some patients experience chronic mild flank discomfort without a clearly identified cause. Reduced ability to concentrate urine (leading to somewhat higher urine output) is present in some patients but is usually mild.
Diagnosis of MSK has evolved with imaging over time. Historically, the diagnosis was often made on intravenous urography (IVU), an older imaging test in which contrast is injected intravenously and X-rays are taken as the contrast is excreted by the kidneys. On IVU, MSK typically shows a characteristic appearance of contrast filling the dilated tubules within the medulla, described as a “bouquet of flowers” or “paintbrush” pattern. IVU is now rarely used, and modern imaging with CT—particularly CT urography, which includes delayed excretory-phase images similar to those obtained on IVU—provides comparable and often better information. CT urography can identify the characteristic tubular dilation, medullary calcifications, and any stones in the collecting system.
Non-contrast CT can identify the characteristic medullary calcifications (medullary nephrocalcinosis) and any stones. Ultrasound may show medullary nephrocalcinosis as bright echogenic areas in the medulla but is less specific and less detailed than CT for evaluation of MSK.
Blood tests including kidney function (creatinine and estimated glomerular filtration rate), calcium, phosphorus, and, in selected patients, other tests are useful. Urinalysis typically shows blood and, when infection is present, signs of infection. Urine culture is important when infection is suspected.
Metabolic evaluation with 24-hour urine studies is important in patients with MSK who have recurrent stones. This evaluation looks for high urine calcium, low urine citrate, high urine oxalate, high urine uric acid, and other findings, and can be used to guide preventive strategies. Testing for distal renal tubular acidosis may be appropriate in specific patients, particularly those with certain patterns of stones or acidosis. Stone analysis when a stone is retrieved provides critical information about the stone type.
Differentiating MSK from other conditions that cause medullary calcifications (such as hypercalcemia from primary hyperparathyroidism, sarcoidosis, or vitamin D excess; or distal renal tubular acidosis without MSK) is important, as the causes have different implications for treatment.
Important to Know
Management of medullary sponge kidney focuses on preventing and treating complications (particularly kidney stones and urinary tract infections), addressing any associated metabolic abnormalities, and monitoring kidney function over the long term. Care is typically coordinated by primary care clinicians and, when needed, urologists, nephrologists (particularly those with expertise in stone disease), and other specialists.
For patients with an incidental MSK diagnosis and no history of stones or symptoms, management typically focuses on adequate fluid intake and periodic monitoring. No specific treatment is required for the anatomical variation itself. Awareness of the diagnosis may be important for future medical care, particularly if kidney-related symptoms develop.
For patients with a history of kidney stones, comprehensive stone prevention is essential and often significantly reduces stone recurrence. Key components include:
Increased fluid intake is one of the most important preventive strategies. The goal is typically to produce at least 2 to 2.5 liters of urine per day (which typically requires drinking somewhat more than that in total fluids). Water is generally preferred, and citrus-based beverages (such as lemon-based drinks) may provide additional benefit by increasing urinary citrate. Sugar-sweetened beverages should generally be limited.
Dietary modifications tailored to the specific metabolic findings and stone type. For patients with high urine calcium, moderate reduction in dietary sodium and animal protein is often recommended, along with adequate (not excessive) calcium intake from food (paradoxically, restricting dietary calcium often increases stone risk rather than reducing it). For patients with high urine oxalate, reducing intake of oxalate-rich foods (such as spinach, nuts, chocolate, and some others) may help. Specific dietary strategies are individualized based on 24-hour urine findings and stone type.
Medications may be recommended for specific metabolic abnormalities. Thiazide diuretics (such as hydrochlorothiazide or chlorthalidone) reduce urine calcium and are commonly used for hypercalciuria. Potassium citrate raises urinary citrate levels and pH, and is useful for hypocitraturia and for helping prevent uric acid stones. Alkali therapy is important in patients with distal renal tubular acidosis. Allopurinol is used for hyperuricosuria or uric acid stones.
Prompt treatment of urinary tract infections is important. Because patients with MSK may be more susceptible to recurrent urinary tract infections (due to urinary stasis in the dilated tubules), symptomatic infections should be promptly evaluated and treated with appropriate antibiotics. Long-term preventive antibiotics are not routinely used but may be considered in specific circumstances.
Treatment of active stones follows standard principles. Small stones may pass spontaneously with hydration, pain control, and, in some cases, medical expulsive therapy. Larger stones or those that do not pass may require ureteroscopy with laser lithotripsy, shock wave lithotripsy, or, less commonly, percutaneous approaches. Stones in patients with MSK can be technically challenging in some cases because of the underlying anatomy, and referral to urologists with experience in stone disease is often beneficial.
Long-term monitoring includes periodic clinical assessment, blood tests for kidney function, urinalysis, and, when appropriate, follow-up imaging. The frequency of monitoring is individualized based on the specific findings, history of stones, and other factors. For patients with recurrent stones, periodic 24-hour urine testing can help assess adherence to preventive strategies and identify new metabolic issues.
For patients with associated distal renal tubular acidosis, treatment with alkali (typically potassium citrate) is important and can help both prevent stones and manage the underlying acidosis. Coordination with nephrology may be beneficial.
Care during pregnancy in patients with MSK requires attention because pregnancy can increase the risk of urinary tract infections and, in some cases, stone-related events. Increased fluid intake, prompt treatment of infections, and coordination with obstetrics are important.
For patients with associated congenital syndromes (such as Beckwith-Wiedemann syndrome or congenital hemihypertrophy), care is coordinated with the broader management of the underlying syndrome.
Care is typically coordinated by primary care clinicians and, when needed, urologists and nephrologists with expertise in stone disease. Imaging and laboratory findings are interpreted alongside the patient’s symptoms, examination, and broader clinical context rather than in isolation.
Patient education plays an important role. Understanding that MSK is a generally benign condition that does not typically progress to kidney failure, the importance of preventive strategies (particularly hydration), the rationale for recommended dietary and medication choices, warning signs of stones or infections, and the meaning of imaging findings all contribute to better outcomes.
Red flag symptoms include severe flank or back pain, high fever with chills (particularly with signs of severe urinary tract infection or possible kidney infection), significant decrease in urine output, significant blood in the urine with clots, symptoms of sepsis (severe illness, low blood pressure, rapid heart rate, confusion), severe abdominal pain, severe nausea and vomiting with dehydration, or rapid clinical deterioration. These warrant prompt or urgent medical evaluation, as they may indicate stone obstruction, infection, or other serious complications.